UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities

Pituitary, 2017-02, Vol.20 (1), p.46-62

2017

Volltextzugriff (PDF)

Acromegaly

Nature reviews. Disease primers, 2019-03, Vol.5 (1), p.20, Article 20

2019

Volltextzugriff (PDF)

Results of a Single-Center Observational 10-Year Survey Study on Recurrence of Hyperprolactinemia after Pregnancy and Lactation

The journal of clinical endocrinology and metabolism, 2013-01, Vol.98 (1), p.372-379

2013

Volltextzugriff (PDF)

Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas

European journal of endocrinology, 2013-09, Vol.169 (3), p.359-366

2013

Volltextzugriff (PDF)

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects

European journal of endocrinology, 2008-10, Vol.159 (4), p.389-397

2008

Volltextzugriff (PDF)

Adverse events associated with somatostatin analogs in acromegaly

Expert opinion on drug safety, 2015-08, Vol.14 (8), p.1213-1226

2015

Volltextzugriff (PDF)

Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias

European journal of endocrinology, 2013-01, Vol.168 (1), p.15-22

2013

Volltextzugriff (PDF)

Medical therapy of pituitary adenomas: Effects on tumor shrinkage

Reviews in endocrine & metabolic disorders, 2009-06, Vol.10 (2), p.111-123

2009

Volltextzugriff (PDF)

Glucose Tolerance and Somatostatin Analog Treatment in Acromegaly: A 12-Month Study

The journal of clinical endocrinology and metabolism, 2009-08, Vol.94 (8), p.2907-2914

2009

Volltextzugriff (PDF)

Impact of Somatostatin Analogs Versus Surgery on Glucose Metabolism in Acromegaly: Results of a 5-Year Observational, Open, Prospective Study

The journal of clinical endocrinology and metabolism, 2009-02, Vol.94 (2), p.528-537

2009

Volltextzugriff (PDF)

Therapy of aggressive pituitary tumors

Expert opinion on pharmacotherapy, 2011-07, Vol.12 (10), p.1561-1570

2011

Volltextzugriff (PDF)

The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission

European journal of endocrinology, 2010-06, Vol.162 (6), p.1035-1042

2010

Volltextzugriff (PDF)

Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?

Pituitary, 2015-10, Vol.18 (5), p.583-591

2015

Volltextzugriff (PDF)

Fertility in Acromegaly: A Single-Center Experience of Female Patients During Active Disease and After Disease Remission

The journal of clinical endocrinology and metabolism, 2023-08, Vol.108 (8), p.e583-e593

2023

Volltextzugriff (PDF)

Investigational therapies for acromegaly

Expert opinion on investigational drugs, 2013-08, Vol.22 (8), p.955-963

2013

Volltextzugriff (PDF)

Growth Hormone-Secreting Tumor Shrinkage after 3 Months of Octreotide-Long-Acting Release Therapy Predicts the Response at 12 Months

The journal of clinical endocrinology and metabolism, 2008-09, Vol.93 (9), p.3436-3442

2008

Volltextzugriff (PDF)

Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects

Clinical endocrinology (Oxford), 2011-02, Vol.74 (2), p.234-240

2011

Volltextzugriff (PDF)

Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal

European journal of endocrinology, 2010-05, Vol.162 (5), p.993-999

2010

Volltextzugriff (PDF)

Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly

Endocrine, 2017-03, Vol.55 (3), p.872-884

2017

Volltextzugriff (PDF)

Acromegaly and Heart Failure

Heart failure clinics, 2019-07, Vol.15 (3), p.399-408

2019

Volltextzugriff (PDF)

The safety of treatments for prolactinomas

Expert opinion on drug safety, 2016-04, Vol.15 (4), p.503-512

2016

Volltextzugriff (PDF)

Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting

Endocrine, 2018-12, Vol.62 (3), p.663-680

2018

Volltextzugriff (PDF)

Pituitary magnetic resonance imaging predictive role in the therapeutic response of growth hormone-secreting pituitary adenomas

Gland surgery, 2019-09, Vol.8 (Suppl 3), p.S150-S158

2019

Volltextzugriff (PDF)

Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status

Journal of endocrinological investigation, 2014-02, Vol.37 (2), p.99-112

2014

Volltextzugriff (PDF)

Somatostatin analogs as a first-line treatment in acromegaly: when is it appropriate?

Current opinion in endocrinology, diabetes, and obesity, 2012-08, Vol.19 (4), p.288-294

2012

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(36)
Buchkapitel
(5)

Sprache

Englisch
(39)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(23)
Endocrinology & Metabolism
(21)
Female
(17)
Male
(13)
Medicine
(12)
Medicine & Public Health
(12)
Acromegaly
(11)
Adult
(11)
Middle Aged
(11)
Acromegaly - Drug Therapy
(10)
Biological And Medical Sciences
(10)
Endocrinology
(10)
Endocrinopathies
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Medical Sciences
(10)
Somatostatin - Analogs & Derivatives
(10)
Vertebrates: Endocrinology
(10)
Somatostatin - Therapeutic Use
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities

Acromegaly

Results of a Single-Center Observational 10-Year Survey Study on Recurrence of Hyperprolactinemia after Pregnancy and Lactation

Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects

Adverse events associated with somatostatin analogs in acromegaly

Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias

Medical therapy of pituitary adenomas: Effects on tumor shrinkage

Glucose Tolerance and Somatostatin Analog Treatment in Acromegaly: A 12-Month Study

Impact of Somatostatin Analogs Versus Surgery on Glucose Metabolism in Acromegaly: Results of a 5-Year Observational, Open, Prospective Study

Therapy of aggressive pituitary tumors

The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission

Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?

Fertility in Acromegaly: A Single-Center Experience of Female Patients During Active Disease and After Disease Remission

Investigational therapies for acromegaly

Growth Hormone-Secreting Tumor Shrinkage after 3 Months of Octreotide-Long-Acting Release Therapy Predicts the Response at 12 Months

Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects

Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal

Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly

Acromegaly and Heart Failure

The safety of treatments for prolactinomas

Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting

Pituitary magnetic resonance imaging predictive role in the therapeutic response of growth hormone-secreting pituitary adenomas

Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status

Somatostatin analogs as a first-line treatment in acromegaly: when is it appropriate?

Suchergebnisse filtern